Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is a pre-filled injection pen — the KwikPen — that delivers tirzepatide once a week under the skin. Each pen contains four weekly doses and is used with a small, replaceable needle. If you've searched for mounjaro images because you want to know what you're dealing with before committing, that's completely reasonable. Here's what the genuine article looks like, and why knowing matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Genuine Mounjaro arrives in a small cardboard outer box, Eli Lilly's branding is clean and restrained, not glossy or heavily stylised. Inside you'll find the KwikPen itself in a sealed inner tray, a Patient Information Leaflet, and a card reminding you to use a fresh needle each time. The box carries the product name, the strength (e.g. 5 mg/0.5 ml), the batch number, the expiry date, and a UK marketing authorisation number. If any of those are absent or blurred, that's a problem worth taking seriously. Ordering through a pharmacy listed on the GPhC register is the only reliable way to ensure the packaging you receive is traceable to a licensed UK supplier.
The pen itself is a matt-finish auto-injector, roughly the size and weight of a thick marker pen. A clear inspection window on the side lets you see the liquid inside, it should be colourless to slightly yellow and free of particles. The device is not glass; it won't shatter in a bag. At the top sits a grey cap, which you remove before use. At the bottom, a purple plunger base shows the dose mechanism. If you want a fuller picture of the medicine before handling it for the first time, our Mounjaro page covers what you need to know about the treatment, from how it works to what to expect.
If you search for tirzepatide images at different strengths, you might expect the pens to look dramatically different. They don't. The KwikPen design is identical across all six strengths; only the label changes. Eli Lilly uses distinct label colours to help patients and pharmacists distinguish 2.5 mg from 5 mg from 7.5 mg and so on, but the device itself, the cap style, the inspection window, and the dose counter are the same. This is useful to know: if someone offers you a pen that looks physically different from the one you've been using, ask questions.
The dose counter is a small numbered window you'll find at the injection end of the device. It starts at four and counts down with each use. You'll hear and feel a click when the dose is delivered. A pen that fails to click, or whose counter doesn't move, should not be used, contact your pharmacy. You can read about the full injection process in the Patient Information Leaflet or on the NHS tirzepatide medicines page, which is clear, plain-English, and worth bookmarking for reference.
If you're curious how the dose schedule looks over time (which pen you'd be on at which point in treatment) our overview of the Mounjaro dose stages walks through the typical titration path without prescribing anything specific.
The MHRA has warned publicly about counterfeit weight-loss pens, and the problem has grown significantly. Around 20 million doses of illegally traded weight-loss medicines, with a street value of roughly £45 million, were seized in 2025 alone. In October 2025, the first illicit UK site manufacturing fake tirzepatide pens was raided in Northampton. Some counterfeit pens found previously contained insulin, not the medicine labelled on the outside.
What makes this difficult is that fakes are increasingly sophisticated. Photographs circulating online of suspect pens show convincing outer boxes, plausible label fonts, and similar pen shapes. The giveaways tend to be: no UK batch number, misspelled text on close inspection, a dose counter that moves too freely or not at all, and a price that sits well below what legitimate supply costs. The MHRA recommends reporting any suspect seller or product via the Yellow Card scheme. You can also verify whether a pharmacy is GPhC-registered before ordering from it, that step takes about thirty seconds and matters more than any image comparison.
For more on the shortage and supply landscape that makes some buyers turn to unverified sellers in the first place, our page on Mounjaro shortages in the UK covers what's been happening. And if you want background on tirzepatide's mechanism and clinical evidence, the tirzepatide overview goes into more depth.
A fair number of people searching for Mounjaro images are really looking for images of what happens at the injection site, redness, bruising, small lumps. Injection-site reactions are among the common side effects reported in clinical trials, and they can be unsettling to see on your own skin if you haven't been told to expect them. The reaction is typically a small raised area of redness that fades within a day or two. Rotating your injection site (abdomen, thigh, upper arm) reduces the likelihood of a persistent lump forming.
Some people also search for images associated with what's sometimes called Mounjaro face, visible changes in facial appearance as weight reduces. That's a separate phenomenon worth understanding before you start treatment. The disadvantages of Mounjaro page addresses the side-effect picture honestly, including what the clinical trials reported and where the genuine uncertainties lie.
Mounjaro is a prescription-only medicine. A prescriber must assess your full medical picture before it's appropriate for you. If you'd like to understand whether you might be eligible, the consultation at our treatment page is free, takes a few minutes, and is reviewed the same day by a real clinician, not software. There's no obligation. Speak to our prescribers if you'd like to take that step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.